An observational study in Addiction and Violence, Domestic, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-31.
Sponsored by University Hospital, Clermont-Ferrand · Observational
Intimate partner violence and addictions are two frequent problematics with many consequences on health. A link between intimate partner violence and addictions has been found in many studies. Being a drug user increases the risk to be a perpetrator and also a victim of intimate partner violence.
So, it is legitimate to question ourselves about the prevalence of the victims and perpetrators of intimate partner violence among the patients consulting or being hospitalized for an addiction problem. We believe that this prevalence will be high among these patients.
On the other hand, the general practitioners are in first line receiving victims and perpetrators of violence and patients with addiction problems. So it is important to know the profiles of these patients and their expectations from their general practitioners.
The different places where the study will take place are:
This study will be based on the filling of self-answered questionnaires by the patients consulting or being hospitalized in the different recruited centers. The questionnaire will be proposed to the patient after the consultation with the practitioner. An information about the study and the anonymity will be given to the patient. The filled questionnaire will be put by the patient in a closed envelope and then in a collection box located in the waiting room.
The different boxes of the different centers will be checked regularly and then the questionnaires will be analysed. The analysis of these questionnaires will allow to describe the population consulting or being hospitalized for addiction problems in the Puy-de-Dôme: age, gender, type of the addiction, the presence of intimate partner violence, associated factors of the violence, recourse characteristics to general practitioners and expectations of GP. We will evaluate the prevalence of victimization and perpetration of intimate partner violence among patients consulting or being hospitalized for addiction problems in the Puy-de-Dôme.
We estimate the duration of the study at around 6 months.
540 studies on the registry are indexed under Behavior, Addictive; 134 are open to participants now.
This study's enrollment of 122 is below the median of 170 across 133 observational studies indexed under Behavior, Addictive.
Browse Behavior, Addictive studies →University Hospital, Clermont-Ferrand is the lead sponsor of 841 studies on the registry; 178 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients consulting or being hospitalized for addiction problems
Exclusion Criteria:
patient consulting or hospitalized in addiction structure
Other: questionnaire
questionnaire for conjugal violence prevalence
Prevalence of the victimization
Prevalence of the victimization and the perpetration of intimate partner violence in patients consulting or being hospitalized for addiction problems who had filled the questionnaire. This prevalence will be measured by the filling of the questions of the self-answered questionnaire by the patients.
Time frame: day 0
Prevalence of each addiction
prevalence will be measured by the filling of the questions of the self-answered questionnaire by the patients.
Time frame: Day 0
Socio-demographic characteristics
age in years
Time frame: Day 0
Socio-demographic characteristics
male or female
Time frame: Day 0
Recourse at general practitioner characteristics
reason and frequency of consultation with their general practitioner
Time frame: Day 0
Expectations by the patients of the general practitioners about addictions and intimate partner violence
qualitative answer
Time frame: Day 0
This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Clermont-Ferrand